Diabetes prevention project coordinated by Diamyd Medical to be presented at scientific conference

The ASSET (AI for Sustainable Prevention of Autoimmunity in the Society) innovation milieu for the development of improved prevention strategies in Type 1 Diabetes, funded by the Swedish innovation agency VINNOVA, will be presented by PhD Ulf Hannelius, CEO of Diamyd Medical, at the Annual Meeting of the Scandinavian Society for the Study of Diabetes (SSSD), to be held in Reykjavík on May 12-13, 2022. The presentation will be given under the title “ASSET- a public/private partnership developing an integrated approach to prevention of Type 1 Diabetes (T1D)”.Diamyd Medical and five other